Pay in 4 interest-free payments of $7.41 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
When to Avoid Increasing Your Dose If youre achieving satisfactory weight loss and experiencing good appetite suppression at your current dose, theres no need to increase the dose further
Common causes include not enough protein, too little overall intake causing your body to downshift its metabolism, dehydration or constipation masking fat loss on the scale, and no strength training causing lean mass to drop faster
Curved Definition : A subtle C-curve is introduced, creating a more dynamic and youthful profile
Store refrigerated until the date indicated
We also offer lipotropic shots (MIC/Lipo-C) and peptides (MIC/Lipo-C) to enhance fat metabolism and boost energy, on their own or in combination with GLP-1s
Currently available GLP-1 receptor agonists in the UK include: Exenatide (short-acting and extended-release formulations) - licensed for type 2 diabetes Liraglutide (once-daily injection) - licensed for type 2 diabetes (Victoza) and separately for weight management (Saxenda 3mg) Dulaglutide (once-weekly injection) - licensed for type 2 diabetes, including cardiovascular risk reduction in those with established cardiovascular disease or multiple risk factors Semaglutide (once-weekly injection and oral formulation) - licensed for type 2 diabetes (Ozempic, Rybelsus) and separately for weight management (Wegovy 2.4mg) A related but distinct medication is tirzepatide (once-weekly injection), which is a dual GIP/GLP-1 receptor agonist licensed for type 2 diabetes management
